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Abstract
Background: White coat hypertension (WCHT) is a significant clinical condition with haemodynamic differences
and presence of functional changes. We aim to compare cognitive and autonomic dysfunction variables (heart rate
variability) between subjects with normal blood pressure (controls), WCHT, and borderline hypertension (BLH).
Methods: We performed a cross-sectional study in a cohort of 69 subjects (mean age ± SD; 38.2 ±10.8 years)
comprising comparable number of normal controls, WCHT, and BLH. We measured clinic and 24-hour ambulatory
blood pressure monitoring (ABPM), cognitive function parameters, and heart rate variability (HRV). All subjects
underwent 24-hour ambulatory electrocardiography monitoring which was analyzed for HRV measurements. We
performed a routine echocardiography (ECHO) for all subjects.
Results: Multiple comparison between the three groups revealed significant (p < 0.04) differences in mean day-
time ABPM (systolic and diastolic). In the state anxiety inventory (SAI), both subjects with WCHT and BLH had
significantly (p < 0.006) higher anxiety levels than the control group. In memory tasks WCHT subjects scored
significantly (p < 0.004) lower in comparison with the other two groups. WCHT significantly (p < 0.001) performed
less in memory tests, whereas BLH subjects had significantly (p < 0.001) lower reaction time. We found a significant
(p < 0.05) difference in the 24-hour RMSSD and SDNN between the three groups. There was significant correlation
between 24-hour RMSSD and computer CANTAB scores. The Echocardiography assessment revealed no significant
differences in LV mass indices and diastolic function.
Conclusions: WCHT and BLH subjects showed lower cognitive performance and higher levels of anxiety when
compared to controls. Autonomic function reflected by HRV indices was lower in WCHT and BLH in contrast to
control, though not significantly. Our results suggest that WCHT may not be a benign condition as it may
contribute to the overall risk for cardiovascular disease and LV damage. Longitudinal studies of patients with WCHT
should clarify the transient, persistent or the progressive nature of this condition.
Background
White coat hypertension (WCHT), a transient increase
in blood pressure (BP) measured in a medical setting, is
a significant clinical condition with haemodynamic
differences and presence of functional vascular changes
and increased peripheral resistance [1,2]. It is not clear
whether WCHT is a variant of hypertension [3] or a rise
in BP during stress [4] especially with regard to cogni-
tive and autonomic dysfunction variables.
To overcome BP fluctuations, ambulatory blood pres-
sure monitoring (ABPM) over a 24-hour period may
p r o v i d em o r ea c c u r a t eB Pr e a d i n g s[ 5 ] .H o w e v e r ,t h e
prognostic significance of ABPM, indicates that there is
no increased cardiovascular risk among WCHT [6].
Epidemiological studies showed that drug treatment
lowered clinic pressure in all patients but had little
effect on the ABPM among patients with WCHT [7,8].
Hence, the assumption that office hypertension should
not be treated in patients with “normal” ABPM may
need to be revisited. In part, because high office BP is
the basis of the existing evidences that hypertension is
harmful, and that treatment of hypertension is indeed
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pared to masked and sustained hypertension, it is never-
theless up-normal [10]. We hypothesize that assessing
the cognitive function and heart rate variability (HRV)
may be of importance in identifying subjects at higher
risk of developing hypertension.
Existing evidence shows that patients with hyperten-
sion performed poorly than normotensive subjects
across multiple domains of neuropsychological function
including memory and attention tasks, awareness of
bodily sensations, and cognitive function; reasoning and
memory [11,12]. More recent research has highlighted
that greater variability in BP on 24-hour ABPM serves
as an index of autonomic deregulation and is associated
with poorer cognitive performance [13].
HRV, known to be associated with development of
many cardiac and non-cardiac diseases [14,15], has been
implicated as a predictor of hypertension [16]. On the
contrary, no differences were shown in HRV among
WCHT as compared to both patients with hypertension
and control subjects [17]. Regardless, population-based
studies indicate increased sympathetic activity among
WCHT in comparison to masked and sustained hyper-
tension [18].
The magnitude of BP increase during mental stress
predicts progression of atherosclerosis more strongly
than baseline BP, cholesterol level, and history of smok-
ing [19]. Even so, while some studies have shown that
target organ damage is less prevalent [20], other studies
reported higher-than-normal left ventricular mass
(LVM) among WCHT patients [21]. As a result, WCHT
may be considered as an intermediate condition between
normotension and hypertension in relation to target
organ damage including carotid stiffness and left ventri-
cular hypertrophy [22].
Therefore, this study aims to compare important clini-
cal indicators i.e. clinic BP, ABPM, cognitive function,
and HRV, across three groups; subjects with normal BP,
WCHT, and BLH.
Methods
Study design
In this cross-sectional study, we recruited a total of sixty
nine individuals including control subjects (n = 20),
WCHT (n = 19), and BLH (n = 30) from among healthy
normal volunteers and visitors of the outpatient hyper-
tension clinic at Wellcome Trust clinical research facil-
ity, University Hospital Birmingham NHS Trust,
Birmingham, United Kingdom.
Subjects
Healthy controls were defined as subjects with normal
BP < 130/80 mm Hg in the clinic and during the day-
time and in the absence of other risk factors. WCHT
was defined as patients with clinic BP > 140/90 mm Hg,
but with ambulatory day-time BP < 135/85 mm Hg.
BLH was defined as patients with systolic BP > 140 mm
Hg and < 160 mm Hg and/or diastolic BP > 90 mm Hg
and < 99 mm Hg both in the clinic and during the
day-time. The Research and Ethics Committee of the
University of Birmingham approved the study protocols
prior to subject recruitment. All subjects gave written
and informed consent to participate in the study.
Methods
Demographic and anthropometric variables as well as
history of smoking, alcohol consumption, and family
history of heart disease (HD) were recorded. All subjects
referred to the clinic had 24-hour ABPM (Spacelabs
Medical, model 90217-validated).
Clinic BP, was measured in the sitting position by
standard oscillometeric sphygmomanometer (Dinamp,
Critikon) with an appropriate cuff size (Dura-cuff, John-
son & Johnson Ltd) attached to the participant’s upper
left arm. The average day-time pressure was used to
determine BP status. Account was taken for the differ-
ences between ABPM measurements and clinic mea-
surements by the addition of 12/7 mm Hg to the mean
day-time pressure taken by ABPM according to guide-
lines [23]. BP levels were classified according to the Brit-
ish Hypertension Guidelines [24].
Cambridge Neuropsychological Test Automated Bat-
tery (CANTAB) computer tests were evaluated in the
three groups by a battery of 5 computerized tests
including paired associates learning task (PALT), spatial
recognition and memory task (SRMT), reaction time
(RT 11), spatial span test (SSPT), and spatial working
memory (SWMT) together with an additional 3 paper
format tests namely Alice Heim 4 (AH4) verbal and
numerical reasoning test, paced auditory serial addition
test (PASAT) and state anxiety inventory (SAI) test -
according to standard procedures.
As detailed previously [25], we measured HRV from
24-hour electrocardiography monitoring calculated in
the time domain and according to standard procedures
[26]. Time-domain measures included the overall varia-
bility in the entire recording, calculated as the standard
deviation (SD) of all normal R-R intervals (SDNN) and
the mean square root of successive differences
(RMSSD). The triangular index was obtained by dividing
the total number of all R-R intervals by the height of
the histogram of all R-R intervals, measured on a
discrete scale with bins of 7.8 ms. Long-term HRV was
estimated using the standard deviation of the mean R-R
values and short-term HRV was estimated in five-
minute periods using the SDNN index, a mean of five-
minute standard deviations of the R-R intervals.ECG
data was summarised as a mean for an individual
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rected to a 24-hour mean value where relevant. Where
applicable, cut-off values of < 100 ms for SDNN and <
25 ms for triangular index (TI) were used.
A routine echocardiogram was performed following a
previously validated protocol [27]. Standardized exami-
nations included 2-D guided M-mode echo-cardiograms
and selected 2-D recordings. Studies were performed
using a high-quality commercially available echocardio-
graph (Sono 2000) equipped with Super-VHS video
recorder. Measurements were made blindly by experi-
enced physician readers. LV hypertrophy was considered
to be present when LV mass index exceeded 116 g/m
2
for men and 104 g/m2 for women, and increased RWT
was present when this ratio exceeded 0.43. Pulsed Dop-
pler recordings of the transmitral flow velocities were
obtained between the tips of the mitral valves, measur-
ing early and atrial LV filling peak flow velocity as well
as deceleration time of early diastolic transmitral flow.
LV filling was considered normal when isovolumetric
relaxation time was < 100 ms, deceleration time between
150 and 250 ms and ratio between early and atrial LV
filling peak flow velocity between 1.0 and 1.5.
All subjects underwent a thorough medical examination
to exclude any chronic illness i.e. diabetes, kidney disease,
and other cardiovascular disorders. Consequently, blood
samples were collected to measure glucose, urea and elec-
trolytes, cholesterol and high-density lipoprotein (HDL)-
cholesterol.
Data analysis
We conducted statistical analysis to compare the differ-
ences in HRV, ABPM and cognitive function among the
three groups. All results were expressed as mean value
± standard error of the mean (SEM). Post hoc test was
used to compare differences between the three groups.
To determine the relationship between HRV and other
measured variables, univariate analysis followed with
multiple regression analysis in a step-wise approach if
variables demonstrated a significant relationship with
HRV. Multiple regression analysis was used to assess
association between HRV parameters and measures of
clinic BP and ABPM. A p value of < 0.05 was consid-
ered to be significant. Correlation analysis between
24-hour RMSSD and other variables were performed to
see if any relationship was apparent between groups.
Results
The demographic and anthropometric characteristics of
the participating subjects are shown in Table 1. The
mean age of the healthy control (mean ± SD; 31 ± 11
years) subjects was slightly less than that of the WCHT
(42 ± 10 years) and BLH (40 ± 9 years) subjects. All
three groups had normal LV mass indices (g/m
2);
control group (104 ± 9), WCHT (109 ± 5), and BLH
subjects (mean ± SD; 110 ± 4). Similarly the three
groups had normal diastolic function. No significant dif-
ferences were observed in smoking habits (p = 0.39),
alcohol consumption (p = 0.91) or family history of
heart disease (p = 0.86) between the three groups.
The mean day-time ABPM (systolic and diastolic)
values were significantly (p < 0.05) higher among
WCHT, and more so among BLH as compared to the
normal control subjects. When compared BP levels
within each group, there was a significant fall in ABPM
(day-time and night-time) compared to clinic BP levels
especially among WCHT subjects. No significant differ-
ences were observed in both the clinic BP and the
night-time ABPM measurements between the three
groups as indicated in Table 2.
CANTAB computer and cognitive tests
A statistically significant difference was observed in the
CANTAB computer test between the three groups. The
mean scores obtained in the computer tests, the Alice
Heim 4 (AH4), the PASAT and the State Anxiety Inven-
tory (SAI) are summarized in Table 3. Both WCHT and
BLH subjects scored significantly higher than the con-
trol group in the PALT challenge score, and significantly
lower than the control in the mean percentage of cor-
rect answers of the spatial recognition and memory task
(SRMT). WCHT and more so BLH subjects had signifi-
cantly lower RT than the control group. In the SSPT
test WCHT were able to recall a longer sequence, on
average, better than BLH subjects, but both groups per-
formed worse than the control group. The same pattern
was evident in the spatial working memory task
(SWMT), where WCHT and BHL subjects achieved a
significantly higher error than the control group.
In summary, it was evident that subjects with WCHT
performed poorly in memory tests (p = 0.001);
whereas BLH subjects seemed to have slower reaction
times (p = 0.001). While, no statistical relevance could
be seen in the results of the AH4 verbal and numerical
test or the PASAT, the mean scores in both tests for
subjects with WCHTs showed the lowest scores. In the
state anxiety inventory (SAI), both subjects with WCHT
and BLH had significantly higher anxiety levels than the
control group (p = 0.006). Multiple comparison between
the three groups revealed significant differences between
control subject scores in memory tasks in comparison
with the other two groups (p = 0.004).
Heart rate variability (HRV) - 24 hour RMSSD
We found a significant (p < 0.5) difference in the 24-hour
RMSSD and SDNN, but not other HRV measures,
between the three groups as shown in Table 4. Further,
the 24-hour RMSSD was negatively correlated with clinic
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HRV value (p = 0.01). Similar observations was made in
the correlation between both 24-hour RMSSD and mean
night-time diastolic BP and clinic diastolic BP (p =
0.001). No significant correlation was evident between
24-hour RMSSD and mean day-time systolic BP (p =
0.37), or mean day-time diastolic BP (p = 0.28) or mean
night-time systolic BP (p = 0.06). Significant correlation
was evident between 24-hour RMSSD and clinic pulse
readings i.e. as pulse count per minute increases, HRV
was reduced (p= 0.001). A very strong correlation was
seen when 24-hour RMSSD was compared against 24-
hour mean heart rate (MHR; p = 0.00).
There was significant correlation between 24-hour
RMSSD and computer CANTAB scores (in 4 out of 5).
The paired associate learning task (PALT; p = 0.00) and
spatial working memory test (SWMT; p = 0.04) revealed
negative correlation with RMSSD i.e. as the scores
increased, HRV decreased. However, although the spatial
span test (SSPT) and the SRMT were significant (p = 0.02
and p = 0.03; respectively) the correlation was positive i.e.
the test scores increased with increasing HRV. No signifi-
cant correlation was found between 24-hour RMSSD and
the state anxiety inventory (p = 0.27), or AH4 verbal and
numerical test (p = 0.55) or the PASAT (p = 0.90).
Echocardiography revealed that compared to the nor-
mal control subjects, both WCHT and BLH subjects
had higher LV mass indices and lower diastolic function
parameters. All subjects were in good health and no
chronic illness was reported as confirmed by routine
laboratory analysis.
Discussion
The primary aim of the project was to compare clinic
BP, AMBP, cognition and HRV between healthy normal
control subjects, WCHT, and BLH subjects.
Existing evidence shows that individuals with WCHT
may develop persistent hypertension over a relatively
short period of time [28]. These findings were based on
t h ep r o g n o s t i cs i g n i f i c a n c eo fA B P Mi nc o m p a r i s o n
with clinic BP measurement [29]. We report a signifi-
cantly higher day-time ABPM (systolic and diastolic)
values among WCHT, and more so among BLH sub-
jects as compared to normal controls. The most impor-
tant difference was seen in a sharp fall of BP (systolic
and diastolic) between clinic-, day-time-, and night-
time- BP readings among the WCHT, and though
slightly less, among BLH subjects. Our results are con-
sistent with available data in the literature [30], and
may, in fact, correspond to the classical diagnostic
Table 1 Demographic and Anthropometric Characteristics of the Subjects Stratified by Blood Pressure
Parameters Normal BP (n = 20) WCH (n = 19) Borderline HTN (n = 30) Total Number (n = 69)
Mean ± SD Mean ± SD Mean ± SD Mean ± SD
Age (years) 31 ± 11 42 ± 10 40 ± 9 38.2 ± 10.8
BMI (kg/m
2) 23 ± 4 26 ± 6 28 ± 5 25.6 ± 5
Gender - (%)
Male 34.3 40.0 25.7 50.7
Female 23.5 14.7 61.8 49.3
Lifestyle - (%)
Smoking 25.0 30.0 45.0 29.0
Alcohol 27.8 27.8 44.4 78.3
FH of HD 29.7 29.7 40.6 53.6
BP; blood pressure, WCH; white coat hypertension, HTN; hypertension, BMI; body mass index, FH of HD; family history of heart disease.
Table 2 Clinic and ambulatory blood pressure monitoring (ABPM)
Parameters Normal BP (N = 20) WCH (N = 19) Borderline HTN (N = 30) Post-hoc analysis
Mean ± SD Mean ± SD Mean ± SD p value
Clinic SBP (mm Hg) 125 ± 18 161 ± 16 155 ± 16 NS
ABPM (day-time) SBP (mm Hg) 121 ± 13 131 ± 8 139 ± 6 < 0.05
ABPM (night-time) SBP (mm Hg) 111 ± 12 118 ± 11 121 ± 9 NS
Clinic DBP (mm Hg) 71 ± 8 93 ± 10 93 ± 11 NS
ABPM (day-time) DBP (mm Hg) 75 ± 7 82 ± 6 90 ± 6 < 0.05
ABPM (night-time) DBP (mm Hg) 65 ± 8 69 ± 10 77 ± 7 NS
Pulse 71 ± 9 86 ± 15 80 ± 19 < 0.05
BP: blood pressure, WCH: white coat hypertension, HTN: hypertension, SD; standard deviation.
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day-time BP of < 135/85 mm Hg, but > 140/90 mm Hg
in the clinic according to the definition of the British
Hypertension Society [24]. However, our data cannot
confirm a foreseeable transition between WCHT to sus-
tained hypertension. Generally, the BP observed between
the groups served as a means of categorizing partici-
pants on the severity of hypertension thereby enabling
comparisons to be made. The comparison of clinic and
24-hour BP has proved that WCHT was apparent in
this sample. It also suggests that borderline subjects
have higher sustained mean BPs over 24-hour. However,
our study did not address, and therefore cannot explain
longitudinal effects of these measurements. Hence,
whether other factors could identify the future prognosis
of these variables in patients with hypertension may rely
on the evidence found when cognitive function and
HRV were assessed.
Five out of the nine CANTAB computer tests revealed
significant differences in performance between the three
groups (post-hoc). It was evident from the mean scores
that WCHT poorly performed in memory tests, whereas
borderline subjects had slower reaction time, but both
groups performed significantly worse than normoten-
sives. These results were consistent with the observa-
tions of Elias and colleagues [31]. In contrast, other
studies [32], have shown no relationship between BP
and cognitive performance. These conflicting results
may reflect several methodological differences in these
studies. It was thought that the negative findings in the
Farmer’s study [32] was most likely due to BP measure-
ments taken simultaneously with neuropsychological
testing, or probably too few measurements were taken.
Our findings agree with Elias et al of BP being inversely
related to cognitive function. Despite the relatively small
sample size, our results indicated a significant lack of
performance in cognitive tests by subjects with WCHT
and borderline when compared to controls.
The state anxiety inventory revealed that subjects with
WCHT and BLH had significantly higher anxiety levels
Table 3 Mean values of the Cambridge Neuropsychological Test Automated Battery (9CANTAB) computer tests and
paper format tests
Normal BP (N = 20) WCH (N = 19) Borderline HTN (N =30) Post-hoc p value
CANTAB computer tests
PALT ± SD 5 ± 5 15 ± 8 12 ± 8 0.069
SRMT ± SD 89 ± 6 71 ± 12 80 ±10 0.004
RT 11 ± SD 335 ± 54 393 ± 50 401 ±70 0.003
SSPT ± SD 7 ± 1 4 ± 2 3 ±3 0.060
SWMT ± SD 19 ± 12 36 ± 16 33 ±18 0.030
Paper format tests
AH 4 ± SD 37 ± 13 30 ± 14 37 ±8 0.004
PASAT ± SD 44 ± 9 37 ± 13 42 ±11 0.003
SAI ± SD 29 ± 3 38 ± 10 36 ±8 0.006
BP; blood pressure, WCH; white coat hypertension, HTN; hypertension, CANTAB9; Nine Cambridge Neuropsychological Test Automated Battery (CANTAB)
computer tests (9), PALT; paired associates learning task, SRMT; spatial recognition and memory task, RT11; reaction time, SSPT; spatial span test, SWMT; spatial
working memory, AH4; Alice Heim 4, PASAT; paced auditory serial addition test, SAI; state anxiety inventory.
Table 4 Comparison of heart rate variability measures between three groups; healthy normal subjects, white coat
hypertension, and borderline hypertension subjects
HRV 24-hours Normal BP (N = 20) WCH (N = 19) BLH (N = 30) Post-hoc
Mean ± SD Mean ± SD Mean ± SD p value
24hr MHR 77 ± 8 71 ± 10 77 ± 8 > 0.05
24hr Triangular Index 43 ± 10 39 ± 16 37 ± 11 > 0.05
SDNN 154 ± 50 149 ± 46 130 ± 33 < 0.05
24hr SDNN Index 71 ± 28 64 ± 25 58 ± 15 > 0.05
SDANN 130 ± 47 130 ± 41 113 ± 32 > 0.05
RMSSD 45 ± 28 33 ± 22 31 ± 14 < 0.05
24IT ±SD 43 ± 10 39 ± 16 37 ± 11 > 0.05
HRV; Heart rate variability, BP; blood pressure, WCH; White coat hypertension, BLH; borderline hypertension, MHR; Mean heart rate, SDNN; Standard deviation
normal to normal interval, SDANN; Standard deviation average normal to normal interval, RMSSD; Square root of the mean squared differences of successive R-R
intervals, 24IT; inspection time.
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group’s lack of performance in most of the cognitive
tests and could clinically be the cause of the high BPs
measured at the hospital i.e. WCHT. Psychological fac-
tors may be closely related to the development of hyper-
tension [33]. However, all BP measurements and
CANTAB computer test results remained significant
even when data was stratified for sex, age and anxiety
scores. Thus, BPs obtained and the computer test scores
were independent of differences in age, sex and anxiety
levels between the three groups. It can be speculated
that these intermediate groups (WCHT and borderline
subjects) will develop sustained hypertension associated
with poor cognitive performance and high levels of anxi-
ety. Such findings raise the possibility that controlling
anxiety levels with these variables may reduce stress and
consequently lower BP. Previous work [34] has sug-
gested that relaxation training can increase parasympa-
thetic tone on the heart thus reducing BP and
increasing HRV. The results show that across neuropsy-
chological testing, subjects with WCHT performed
poorly in memory tests, whereas subjects with BLH
showed slower reaction time, compared with controls.
Recently HRV has also been utilised as a predictor of
hypertension [16]. The latter study indicated that con-
trol male participants with lower HRV had a greater risk
of developing hypertension. Our study showed that sub-
jects with borderline hypertension had lower HRV
indices than subjects with WCHTs and normotensives
(p > 0.05). It is worth noting that when 24-hour RMSSD
was compared against sex, there was significant differ-
ence between the three groups (p < 0.05). This may
indicate a greater effect of gender on the RMSSD values
of subjects than the group type i.e. subject’s BP. There-
fore it can be predicted that if groups were gender
matched, then significant and clinical differences in
HRV domains may become apparent. The 24-hour
RMSSD correlated significantly with clinic systolic, clinic
diastolic, mean night-time diastolic, clinic pulse and
mean heart rate values. All these correlations were nega-
tive. Thus an increased BP and pulse values was asso-
ciated with a decreased 24-hour RMSSD (and hence
HRV) and; a finding that supports the possible associa-
tion between high BP and low HRV.
Significant correlation was also evident between four
out of the five computer cognition tests. Negative corre-
lation between 24-hour RMSSD, PALT and the SWMT
was evident. This suggests that greater number of errors
in these tests (i.e. poor cognition) may be linked to low
HRV. However, there was positive correlation between
24-hour RMSSD and SSPT and the SRMT. The scores
for these tests were based on the number of correct
answers, so the positive correlation suggests that low
scores (i.e. poor cognition) are linked to low HRV. This
correlation entails significant association of low HRV
with high BP and poor cognitive performance in this
sample, but the differences between the groups were not
significant.
Echo cardiography revealed that compared to control
subjects, both WCHT and BLH subjects had normal but
thicker left ventricular (LV) mass and normal but
reduced diastolic function. This is important because
detecting signs of organ damage in WCHT may further
help physicians to correctly plan antihypertensive ther-
apy, particularly, among patients at higher risk of CVD
and other organ damage i.e. CKD from excessive BP
reduction [35].
Taken together, the findings from this study cannot
answer the question of whether to treat or not treat
WCHT, in part, because of the cross-sectional nature of
the study, and indeed the relatively smaller sample size.
Nonetheless, the current study may provide new insights
on the basis of associated new surrogate risks i.e. cogni-
tive and HRV dysfunction
Study limitations
Firstly, we did not record the exact time of BP measure-
ments in the clinic. Moreover, no standardized measures
were taken to reduce the stressor “pressor effects” of the
clinic setting. Secondly, unmeasured confounders such
as education [36], may have affected the current cogni-
tive function results. Longitudinal data may be required
to produce a clearer understanding of the effects of cog-
nition on clinic and ambulatory BP values over time.
Thirdly, the small sample size used in our study may
have concealed the true differences in HRV among the
groups. The lack of any relationship between group type
and HRV was most likely due to the lack of group parti-
cipants and failure of gender-matching.
Conclusions
WCHT subjects performed poorly in memory tests,
whereas BLH subjects had slower reaction time, but
both groups performed significantly worse than controls.
Autonomic functions reflected by HRV indices were
lower in WCHT and BLH subjects in contrast to con-
trols though not statistically significant. We noted that
the structural changes found in the left ventricle among
the WCHT subjects; including increased normal LV
mass, and decreased normal diastolic function may con-
tribute to the overall risk for cardiovascular disease and
mortality. Therefore, WCHT may not be considered a
benign condition, but rather a condition that can result
in LV damage. Longitudinal studies of patients with
WCHT should clarify the transient, persistent or the
progressive nature of this condition.
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